analytics_image
\
Vantage Market Research
Vantage Market Research

Reports - Chemotherapy Devices Market

iconHealthcare

Chemotherapy Devices Market

Chemotherapy Devices Market by Product (Catheter, Cannula, Pump, Others), by Application (Hospital, Clinics, Home Care), by Region (North America, Europe, Asia Pacific, Latin America) - Historic Data (2021 - 2023) & Forecast Period (2025 - 2035)

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 0.21 Billion

Market Size By 2035

USD 0.394 Billion

CAGR (2025 - 2035)

5.95%

Largest Region

North America

Fastest Region

Asia Pacific

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Product, By Application, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview

Chemotherapy Devices Market: By Product, Application and Region

Market Synopsis:

Chemotherapy Devices Market Size, 2024 To 2035 (USD Billion)

The global Chemotherapy Devices Market is valued at USD 0.21 Billion in 2024 and is projected to reach a value of USD 0.394 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 5.95% between 2025 and 2035. Chemotherapy is given intravenously with the help of a venous access device (VAD). Cannulas, catheters, and implanted ports are only a few of the devices accessible. The gadget selected is determined by the sort of therapy a patient will receive as well as the patients physical condition. A central venous access device (CVAD) is a non-irritating device constructed of silicone that can be left in place for weeks or months. CVADs can be used to give fluids and medications as well as take blood samples. The external and internal jugular veins, as well as the subclavian veins, are the most common locations for central venous access devices. The cephalic vein in the deltopectoral groove, the axillary vein, and the femoral vein are all possible entry points.

The rising prevalence of cancer and the failure of traditional cancer treatments to adequately treat the disease has fueled demand for innovative immunotherapy-based therapeutics such Chemotherapy Devices. According to the National Cancer Institute, 16.8 million new instances of cancer were diagnosed in the United States in 2016, with an estimated 595,690 deaths from the disease. By 2024, the number of cancer patients is predicted to reach 19 million. In addition, the World Health Organization (WHO) recorded around 14 million cancer cases and 8.2 million cancer-related deaths in 2012. Lung, colorectal, prostate, cervical, and breast cancer were among the most common occurrences, which has resulted in a substantial increase in demand for peptide vaccines, which has aided in the growth of the Chemotherapy Devices industry.



Rising Cancer Incidences

According to research published by the World Health Organization (WHO), cancer is the second biggest cause of death worldwide, accounting for 9.6 million deaths in 2018. The key causes of the rise in cancer incidence rates are rising tobacco and alcohol consumption, as well as a growing senior population. Tobacco smoking is a substantial risk factor for cancer, according to the Global Burden of Disease 2015 research, accounting for roughly 22% of cancer deaths globally.

Furthermore, as the incidence of cancer rises, so does the demand for treatment, propelling the worldwide chemotherapy devices market forward. According to the National Cancer Institute (NCI), 15.5 million cancer survivors were recorded in the United States in 2016, with the number likely to rise.



Discomfort to Patients

Patients may experience discomfort as a result of chemotherapy equipment. The needle or guide wire can damage the top of the lung during the insertion of a skin-tunneled catheter or port, generating an air pocket. There may be bruising at the location where the needle entered the vein, or an artery or nerve may be damaged. Furthermore, infection is a possibility. The risk is usually one to three in every 100 instances, although it might be higher based on a variety of other circumstances, such as diagnosis or therapy. Theres also the possibility of a clot forming around the port. The CVAD can split, become damaged, or become dislocated if it is not in the proper position, so it must be replaced.

The Chemotherapy Devices market scope can be tabulated as below:


Market Segmentation:

The Global Chemotherapy Devices Market can be segmented by Product into Catheter, Cannula, Pump and Others. Based on Application into Hospital, Clinics and Home Care. Based on Region, the Chemotherapy Devices Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.



North America to Continue Dominating the Chemotherapy Devices Market

In 2021, North America held the greatest proportion of the global market for Chemotherapy Devices, followed by Europe. The increase in the number of cancer patients, improved health care infrastructure, increased government investments, and other, and ongoing projects will boost the market in the North American region. Furthermore, the rising prevalence of cancer is likely to boost Chemotherapy Devices market growth.

Key Players:

Key participants operating in the Chemotherapy Devices market are: Advanced Chemotherapy Technologies (US)

The Chemotherapy Devices market is segmented as follows:

Market Segmentation

ParameterDetails
Segment Covered

By Product

  • Catheter (26.7%)
  • Cannula
  • Pump
  • Others

By Application

  • Hospital (56.7%)
  • Clinics
  • Home Care

By Region

  • North America (U.S., Canada, Mexico) (38.9%)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa
Companies Covered
  • Advanced Chemotherapy Technologies (US)
  • Baxter International (US)
  • Becton Dickinson (US)
  • B. Braun (Germany)
  • Fresenius Kabi (Germany)
  • Halyard Health (US)
  • ICU Medical (US)
  • Moog Inc (US)
  • Micrel Medical (Sweden)
  • Smiths Group (UK)
  • Terumo Corporation (Japan)
  • and Zyno Medical (US).
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options

Report coverage & Deliverables

Our PDF Reports And Online Dashboard
Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by
Chemotherapy Devices Market Valuation and Growth Forecast 2025-2035